These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 8026159
1. Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534. Jones RN, Sanchez ML. Diagn Microbiol Infect Dis; 1994 Jan; 18(1):61-8. PubMed ID: 8026159 [Abstract] [Full Text] [Related]
2. In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents. Beskid G, Fallat V, Lipschitz ER, McGarry DH, Cleeland R, Chan K, Keith DD, Unowsky J. Antimicrob Agents Chemother; 1989 Jul; 33(7):1072-7. PubMed ID: 2782857 [Abstract] [Full Text] [Related]
3. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents. McCarter YS, Mazens-Sullivan MF, Bartlett RC. Chemotherapy; 1992 Jul; 38(5):308-18. PubMed ID: 1337507 [Abstract] [Full Text] [Related]
4. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems. Jones RN, Erwin ME, Barrett MS, Johnson DM, Briggs BM. Diagn Microbiol Infect Dis; 1991 Jul; 14(4):301-9. PubMed ID: 1889181 [Abstract] [Full Text] [Related]
5. Antimicrobial activity of Ro 23-9424, a novel ester-linked codrug of fleroxacin and desacetylcefotaxime. Jones RN, Barry AL, Thornsberry C. Antimicrob Agents Chemother; 1989 Jun; 33(6):944-50. PubMed ID: 2504106 [Abstract] [Full Text] [Related]
7. In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics. Gu JW, Neu HC. Antimicrob Agents Chemother; 1990 Feb; 34(2):189-95. PubMed ID: 2327765 [Abstract] [Full Text] [Related]
8. Antimicrobial activity of Ro 24-6778, a covalent bonding of desmethylfleroxacin and desacetylcefotaxime. Jones RN. Diagn Microbiol Infect Dis; 1990 Feb; 13(3):253-9. PubMed ID: 2116952 [Abstract] [Full Text] [Related]
9. Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218. Johnson DM, Jones RN. Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):181-8. PubMed ID: 1396735 [Abstract] [Full Text] [Related]
10. In vitro activity of Ro 23-9424, ceftazidime, and eight other newer beta-lactams against 100 gram-positive blood culture isolates. Jones RN, Barry AL. Diagn Microbiol Infect Dis; 1989 Feb; 12(2):143-7. PubMed ID: 2666014 [Abstract] [Full Text] [Related]
11. In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents. Rolston KV, Nguyen HT, Ho DH, LeBlanc B, Bodey GP. Antimicrob Agents Chemother; 1992 Apr; 36(4):879-82. PubMed ID: 1503453 [Abstract] [Full Text] [Related]
12. In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin. Jones RN, Erwin ME. Antimicrob Agents Chemother; 1992 Jan; 36(1):233-8. PubMed ID: 1590695 [Abstract] [Full Text] [Related]
16. Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime. Frei R, Jones RN, Pignatari AC, Yamane N, Marco F, Hoban DJ. Diagn Microbiol Infect Dis; 1994 Mar; 18(3):167-73. PubMed ID: 7924209 [Abstract] [Full Text] [Related]
19. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone. Qadri SM, Ueno Y, Burns JJ, Almodovar E, Rabea N. Chemotherapy; 1992 Mar; 38(2):99-106. PubMed ID: 1317282 [Abstract] [Full Text] [Related]
20. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin. Barry AL, Fuchs PC. J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012 [Abstract] [Full Text] [Related] Page: [Next] [New Search]